![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/625542-134x100.jpg)
Cleaning validation failures are a leading cause of FDA 483 observations and warning letters, putting pharmaceutical companies at risk of compliance violations, operational downtime, and costly rework. Understand the FDA’s latest stance on cleaning validation in order to avoid increased production delays due to cleaning issues. Includes a free audit-ready checklist to help mitigate the risk of product contamination and recalls.